BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19953430)

  • 1. [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].
    Siegmann KC; Müller KT; Vogel U; Krauss K; Claussen CD
    Rofo; 2010 Jun; 182(6):493-500. PubMed ID: 19953430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy.
    Demartini WB; Lehman CD; Peacock S; Russell MT
    Acad Radiol; 2005 Jul; 12(7):806-14. PubMed ID: 16039534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
    Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
    Martincich L; Montemurro F; Cirillo S; Marra V; De Rosa G; Ponzone R; Aglietta M; Regge D
    Radiol Med; 2003; 106(1-2):51-8. PubMed ID: 12951551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
    Kang DK; Kim TH; Han TS; Kim KS; Yim H
    J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
    Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
    Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
    Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
    J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
    Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic breast MRI in the course of neoadjuvant chemotherapy: standardized evaluation of tumor size and enhancement parameters in correlation to different histopathologic characteristics.
    Schlossbauer T; Sourbron S; Scholz A; Mosner M; Kahlert S; Böhm H; Reiser M; Hellerhoff K
    Acad Radiol; 2010 Apr; 17(4):441-9. PubMed ID: 20207315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic breast MR imaging: current status and future directions.
    Morris EA
    Radiol Clin North Am; 2007 Sep; 45(5):863-80, vii. PubMed ID: 17888774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.